ATC Group: C10AA05 Atorvastatin

Position of C10AA05 in the ATC hierarchy

Level	Code	Title
1	C	Cardiovascular system
2	C10	Lipid modifying agents
3	C10A	Lipid modifying agents, plain
4	C10AA	HMG CoA reductase inhibitors
5	C10AA05	Atorvastatin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	20 mg

Active ingredients in C10AA05

Active Ingredient
Atorvastatin
Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase. Atorvastatin lowers plasma cholesterol and lipoprotein serum concentrations by inhibiting HMG-CoA reductase and subsequently cholesterol biosynthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.

Related product monographs

Document	Type	Information Source
ASPAVOR Film-coated tablet	MPI, Generic	Web Search
ATORSTAN Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
DEZZOLIP Film-coated tablet	MPI, Generic	Health Products Regulatory Authority (ZA)
LESTAVOR Film-coated tablet	MPI, Generic	Marketing Authorisation Holder
LIPITOR Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
LIPITOR Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicines in this ATC group

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.